ASSOCIATION BETWEEN SAFETY, EFFICACY AND HYDROXYCHLOROQUINE DOSAGE IN THE TREATMENT OF CUTANEOUS LUPUS ERYTHEMATOSUS AND SYSTEMIC LUPUS ERYTHEMATOSUS

被引：0
|
作者：
Wakiya, R. [1 ]
Kameda, T. [1 ]
Lzumikawa, M. [1 ]
Nakashima, S. [1 ]
Shimada, H. [1 ]
Ozaki, H. [1 ]
Kondo, A. [1 ]
Kadowaki, N. [1 ]
Dobashi, H. [1 ]
机构：
[1] Kagawa Univ, Dept Internal Med, Div Hematol Rheumatol & Resp Med, Takamatsu, Kagawa, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.3928
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0465
引用
收藏
页码：1213 / 1213
页数：1
相关论文
共 50 条
  • [21] Follicular lupus erythematosus: a new cutaneous manifestation of systemic lupus erythematosus
    Morihara, K
    Kishimoto, S
    Shibagaki, R
    Takenaka, H
    Yasuno, H
    BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (01) : 157 - 159
  • [22] Understanding How Cutaneous Lupus Erythematosus Progresses to Systemic Lupus Erythematosus
    Chong, Benjamin F.
    JAMA DERMATOLOGY, 2014, 150 (03) : 296 - 296
  • [23] Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose
    Wakiya, Risa
    Kameda, Tomohiro
    Nakashima, Shusaku
    Shimada, Hiromi
    Mansour, Mai Mahmoud Fahmy
    Kato, Mikiya
    Miyagi, Taichi
    Kadowaki, Norimitsu
    Dobashi, Hiroaki
    INTERNAL MEDICINE, 2020, 59 (17) : 2105 - 2112
  • [24] Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus
    Ezra, N.
    Jorizzo, J.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2012, 37 (04) : 327 - 334
  • [25] Successful treatment with hydroxychloroquine for systemic lupus erythematosus with cutaneous involvement accompanied by a xanthomatous reaction
    Takezawa, K.
    Ueda-Hayakawa, I
    Yamazaki, F.
    Kambe, N.
    Son, Y.
    Okamoto, H.
    LUPUS, 2020, 29 (01) : 79 - 82
  • [26] Association of Smoking With Cutaneous Manifestations in Systemic Lupus Erythematosus
    Bourre-Tessier, Josiane
    Peschken, Christine A.
    Bernatsky, Sasha
    Joseph, Lawrence
    Clarke, Ann E.
    Fortin, Paul R.
    Hitchon, Carol
    Mittoo, Shikha
    Smith, C. Douglas
    Zummer, Michel
    Pope, Janet
    Tucker, Lori
    Hudson, Marie
    Arbillaga, Hector
    Esdaile, John
    Silverman, Earl
    Chedeville, Gaelle
    Huber, Adam M.
    Belisle, Patrick
    Pineau, Christian A.
    ARTHRITIS CARE & RESEARCH, 2013, 65 (08) : 1275 - 1280
  • [27] Population Pharmacokinetics of Hydroxychloroquine in Japanese Patients With Cutaneous or Systemic Lupus Erythematosus
    Morita, Shigemichi
    Takahashi, Toshiya
    Yoshida, Yasushi
    Yokota, Naohisa
    THERAPEUTIC DRUG MONITORING, 2016, 38 (02) : 259 - 267
  • [28] Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus
    Josefina Cortés-Hernández
    Gabriela Ávila
    Miquel Vilardell-Tarrés
    Josep Ordi-Ros
    Arthritis Research & Therapy, 14
  • [29] Efficacy and safety of methotrexate (MTX) in articular and cutaneous manifestations of systemic lupus erythematosus
    Islam, N.
    Hossain, M.
    Haq, S. Atiqul
    Alam, M. Noor
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 199 - 199
  • [30] Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus
    Cortes-Hernandez, Josefina
    Avila, Gabriela
    Vilardell-Tarres, Miquel
    Ordi-Ros, Josep
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (06)
12345